According to KOBAYASHI Pharmaceutical's latest financial reports the company's current revenue (TTM ) is ยฃ0.82 Billion. a decrease over the revenue in the year 2023 that were of ยฃ0.95 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | ยฃ0.86 B | -9.68% |
2023 | ยฃ0.95 B | -7.1% |
2022 | ยฃ1.02 B | 0.43% |
2021 | ยฃ1.02 B | -1.79% |
2020 | ยฃ1.04 B | -10.21% |
2019 | ยฃ1.16 B | -2.7% |
2018 | ยฃ1.19 B | 15.69% |
2017 | ยฃ1.03 B | |
2015 | ยฃ0.75 B | -0.21% |
2014 | ยฃ0.76 B | 1.92% |
2013 | ยฃ0.74 B | -19.95% |
2012 | ยฃ0.93 B | -12.49% |
2011 | ยฃ1.06 B | 9.57% |
2010 | ยฃ0.97 B | 14.63% |
2009 | ยฃ0.84 B |